0001209191-14-077802.txt : 20141223
0001209191-14-077802.hdr.sgml : 20141223
20141223172516
ACCESSION NUMBER: 0001209191-14-077802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141223
FILED AS OF DATE: 20141223
DATE AS OF CHANGE: 20141223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 850
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 850
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BROWN JAMES F
CENTRAL INDEX KEY: 0001624379
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 141307786
MAIL ADDRESS:
STREET 1: C/O LANDMARK INFRASTRUCTURE PARTNERS LP
STREET 2: 2141 ROSECRANS AVENUE, SUITE 2100
CITY: EL SEGUNDO
STATE: CA
ZIP: 90245
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-12-23
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001624379
BROWN JAMES F
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
1
0
0
0
Common Stock
2014-12-23
4
C
0
679650
A
679650
I
By AVG Ventures, LP
Common Stock
2014-12-23
4
C
0
202372
A
882022
I
By AVG Ventures, LP
Common Stock
2014-12-23
4
J
0
23300
0.00
A
905322
I
By AVG Ventures, LP
Series B Convertible Preferred Stock
2014-12-23
4
C
0
1155405
0.00
D
Common Stock
679650
0
I
By AVG Ventures, LP
Series C Convertible Preferred Stock
2014-12-23
4
C
0
344033
0.00
D
Common Stock
202372
0
I
By AVG Ventures, LP
The Reporting Person is the manager of AVG Ventures GP, LLC, which is general partner of AVG Ventures, LP, which owns the reported securities. The Reporting Person shares voting and investment power with respect to shares held by AVG Ventures, LP. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Reflects 1.7-for-1 reverse stock split which became effective on December 5, 2014.
The Series B Convertible Preferred Stock converted into the Issuer's common stock on a 1.7-for-1 basis and had no expiration date.
The Series C Convertible Preferred Stock converted into the Issuer's common stock on a 1.7-for-1 basis and had no expiration date.
On December 4, 2014, the Board of Directors of the Issuer declared a dividend payable to all holders of records of the Series B Convertible Participating Preferred Stock of the Issuer on December 16, 2014, payable in the form of cash or in shares of Common Stock of the Issuer, at the option of each holder. The dividends occurred in connection with the closing of the Issuer's public offering. The Reporting Person elected to receive the shares of Common Stock.
/s/ James F. Brown
2014-12-23